Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 270-279

  Liu, Chih Peng ^a   Tsai, Wei Jern ^a,b,c   Shen, Chien Chang ^b   Lin, Yun Lian ^b   Liao, Jyh Fei ^a   Chen, Chieh Fu ^a,e   Kuo, Yuh Chi ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b National Research Institute of Chinese Medicine   (Taiwan)

^c National Tai Tung University   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e Qing Dao University   (China)

Author keywords

(S) armepavine; Anti dsDNA autoantibody; IL 2; Immune complex deposition; Splenocyte proliferation; Systemic lupus erythematosus

Indexed keywords

ARMEPAVINE; CYCLOSPORIN A; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; GENE EXPRESSION REGULATION; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNE COMPLEX DEPOSITION; IMMUNOPHARMACOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; LYMPHADENOPATHY; MEDICINAL PLANT; MOUSE; MOUSE STRAIN; NELUMBO NUCIFERA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SPLEEN CELL; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ALKALOIDS; ANIMALS; ANTIBODIES, ANTINUCLEAR; BENZYLISOQUINOLINES; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; MICE; MICE, INBRED MRL LPR; NELUMBO; PHYTOHEMAGGLUTININS; PHYTOTHERAPY; PROTEINURIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEEDS; SPLEEN; SURVIVAL RATE;

EID: 32044449382     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.062     Document Type: Article

References (48)

1. E.T. Andreakos, B.M. Foxwell, F.M. Brennan, R.N. Maini, and M. Feldmann Cytokines and anti-cytokine biologicals in autoimmunity: present and future Cytokine Growth Factor Rev. 13 2002 299 313
2. J.E. Balow, H.A. Austin, L.R. Muenz, K.M. Joyce, T.T. Antonovych, J.H. Klippel, A.D. Steinberg, P.H. Plotz, and J.L. Decker Effect of treatment on the evolution of renal abnormalities in lupus nephritis N. Engl. J. Med. 311 1984 491 495
3. N. Cambridge, and E.S.J. Robinson Effect of BU98008, an imidazoline1-binding site ligand, on body temperature in mice Eur. J. Pharmacol. 519 2005 86 90
4. C.E. Carvalho-Pinto, M.I. Garcia, M. Mellado, J.M. Rodriguez-Frade, J. Martin-Caballero, J. Flores, C. Martinez-A, and D. Balomenos Autocrine production of IFN-γ by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice J. Immunol. 169 2002 1058 1067
5. J.E. Castro, J.A. Listman, B.A. Jacobson, Y. Wang, P.A. Lopez, S. Ju, P.W. Finn, and D.L. Perkins Fas modulation of apoptosis during negative selection of thymocytes Immunity 5 1996 617 627
6. W.F. Clark Treatment of lupus nephritis: immunosuppression, general therapy, dialysis and transplantation Clin. Invest. Med. 17 1994 588 601
7. R. Clynes, J.S. Maizes, R. Guinamard, M. Ono, T. Takai, and J.V. Ravetch Modulation of immune complex induced inflammation in vitro by the coordinate expression of activation and inhibitory Fc receptors J. Exp. Med. 189 1999 179 186
8. P.L. Cohen, and R.A. Eisenberg Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease Annu. Rev. Immunol. 9 1991 243 269
9. J.M. Cruse, R.E. Lewis, and S. Dilioglou Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice Exp. Mol. Pathol. 69 2000 211 222
10. A. Csiszar, G. Nagy, P. Gergely, T. Pozsonyi, and E. Pocsik Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) Clin. Exp. Immunol. 122 2000 464 470
11. M.R. Ehrenstein, D.R. Katz, M.H. Griffiths, L. Papadaki, T.H. Winkler, J.R. Kalden, and D.A. Isenberg Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice Kidney Int. 48 1995 705 711
12. R. Exley, P. Iturriaga-Vasquez, R.J. Lukas, E. Sher, B.K. Cassels, and I. Bermudez Evaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptors Br. J. Pharmacol. 146 2005 15 24
13. M. Falcone, and N. Sarvetnick Cytokines that regulate autoimmune responses Curr. Opin. Immunol. 11 1999 670 676
14. D.T. Felson, and J. Anderson Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis N. Engl. J. Med. 311 1984 1528 1533
15. D.A. Fox, and W.J. McCune Immunosuppressive drug therapy of systemic lupus erythematosus Rheum. Dis. Clin. North Am. 20 1994 265 299
16. H. Friehe, and P. Ney Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride Arzneimittelforschung 47 1997 132 144
17. R.A. Goldsby, T.J. Kindt, and B.A. Osborne Kuby Immunology Fourth ed. 2001 W. H. Freeman and company. New York NY 512
18. E.L. Greidinger, T. Gazitt, K.F. Jaimes, and R.W. Hoffman Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production Arthritis Rheum. 50 2004 2216 2222
19. F. Hong, J. Lee, Y.J. Piao, Y.K. Jae, Y.J. Kim, C. Oh, J.S. Seo, Y.S. Yun, C.W. Yang, J. Ha, and S.S. Kim Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity Biochem. Biophys. Res. Commun. 316 2004 1073 1080
20. D.A. Horwitz, H. Wang, and J.D. Gray Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA Lupus 3 1994 423 428
21. D.A. Jabs, C.L. Burek, Q. Hu, R.C. Kuppers, B. Lee, and R.A. Prendergast Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/MpJ-lpr/lpr mice Cell. Immunol. 141 1992 496 507
22. G.M. Jow, Y.C. Wu, J.H. Guh, and C.M. Teng Armepavine oxalate induces cell death on CCRF-CEM leukemia cell line through an apoptotic pathway Life Sci. 75 2004 549 557
23. D.R. Koh, A. Ho, A. Rahemtulla, W.P. Fung-Leung, H. Griesser, and T.W. Mak Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells Eur. J. Immunol. 25 1995 2558 2562
24. Y.C. Kuo, N.S. Yang, C.J. Chou, L.C. Lin, and W.J. Tsai Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura Mol. Pharmacol. 58 2000 1057 1066
25. Y.C. Kuo, Y.L. Huang, C.C. Chen, Y.S. Lin, K.A. Chuang, and W.J. Tsai Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei J. Lab. Clin. Med. 140 2002 176 187
26. C.P. Liu, W.J. Tsai, Y.L. Lin, J.F. Liao, C.F. Chen, and Y.C. Kuo The extracts from Nelumbo nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells Life Sci. 75 2004 699 716
27. L. Llorente, Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B.M. Fourrier, P. Galanaud, and D. Emilie In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity Arthritis Rheum. 37 1994 1647 1655
28. C.C. Mok, and C.S. Lau Pathogenesis of systemic lupus erythematosus J. Clin. Pathol. 56 2003 481 490
29. P.K. Mukherjee, K. Saha, J. Das, M. Pal, and B.P. Saha Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera Planta Med. 63 1997 67 369
30. L.J. Murray, R. Lee, and C. Martens In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse Eur. J. Immunol. 20 1990 163 170
31. S. Nagata Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model J. Hum. Genet. 43 1998 2 8
32. U.E. Nydeggar A place for soluble immune complexes in clinical immunology Immunol. Today 6 1985 80 82
33. G. Perez de Lema, F.J. Lucio-Cazana, A. Molina, B. Luckow, H. Schmid, C. de Wit, V. Moreno-Manzano, B. Banas, F. Mampaso, and D. Schlondorff Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease Kidney Int. 66 2004 1018 1028
34. S. Philipov, N. Ivanovska, R. Istatkova, M. Velikova, and P. Tuleva Phytochemical study and cytotoxic activity of alkaloids from Uvaria chamae P Beauv. Pharmazie 55 2000 688 689
35. J. Radhakrishnan, C.L. Kunis, V. D'Agati, and G.B. Appel Cyclosporine treatment of lupus membranous nephropathy Clin. Nephrol. 42 1994 147 154
36. I. Romics, D.L. Molnar, G. Timberg, B. Mrklic, B. Jelakovic, G. Koszegi, and G. Blasko The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones BJU Int. 92 2003 92 96
37. S.J. Rozzo, C.G. Drake, B.L. Chiang, M.E. Gershwin, and B.L. Kotzin Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus J. Immunol. 153 1994 1340 1351
38. G.G. Singer, and A.K. Abbas The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice Immunity 1 1994 365 371
39. N. Suzuki, M. Ichino, S. Mihara, S. Kaneko, and T. Sakane Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus Arthritis Rheum. 41 1998 344 353
40. S.J. Szabo, B.M. Sullivan, S.L. Peng, and L.H. Glimcher Molecular mechanisms regulating TH1 immune responses Annu. Rev. Immunol 21 2003 713 758
41. M.J. Talukder, and J. Nessa Effect of Nelumbo nucifera rhizome extract on the gastrointestinal tract of rat Bangladesh Med. Res. Counc. Bull. 24 1998 6 9
42. E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 25 1982 1271 1277
43. C.G. Tsokos, M.P. Nambiar, K. Tenbrock, and Y.T. Juang Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE Trends Immunol. 24 2003 259 263
44. W.Y. Wang, C.P. Liu, Y.C. Kuo, and Y.L. Lin Anti-lymphoproliferative alkaloids from plumula nelumbinis Chin. Pharm. J. 56 2004 25 30
45. M.M. Ward, E. Pyun, and S. Studenski Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus Arch. Intern. Med. 156 1996 1337 1344
46. L.Y. Yang, A. Chen, Y.C. Kuo, and C.Y. Lin Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice J. Lab. Clin. Med. 134 1999 492 500
47. J. Yu, and W.S. Hu Effects of neferine on platelet aggregation in rabbits Yaoxue Xuebao 32 1997 1 4
48. R. Zimmerman, J. Radhakrishnan, A. Valeri, and G. Appel Advances in the treatment of lupus nephritis Annu. Rev. Med. 52 2001 63 78